Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 3Phase 2 1

Status

Completed 3Unknown 2Terminated 2Withdrawn 1

Sponsor Class

INDUSTRY 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other neoplasm 3

Conditions

Neoplasms 1330Breast Neoplasms 686Carcinoma, Non-Small-Cell Lung 543Neoplasm Metastasis 436Lymphoma 435Leukemia, Myeloid, Acute 432Melanoma 402Prostatic Neoplasms 380Multiple Myeloma 364Lymphoma, Non-Hodgkin 355Ovarian Neoplasms 343Colorectal Neoplasms 333Precursor Cell Lymphoblastic Leukemia-Lymphoma 328Pancreatic Neoplasms 328Leukemia, Lymphocytic, Chronic, B-Cell 323Leukemia 282Lung Neoplasms 275Glioblastoma 266Unspecified Adult Solid Tumor, Protocol Specific 257Recurrence 252Lymphoma, Follicular 248Lymphoma, Large B-Cell, Diffuse 245Brain Neoplasms 232Lymphoma, Mantle-Cell 210Carcinoma, Renal Cell 193Hodgkin Disease 192Head and Neck Neoplasms 192Myelodysplastic Syndromes 187Burkitt Lymphoma 172Glioma 171

Interventions

tipifarnib 1Sorafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Completed × Advanced Malignant Neoplasm × Clear all
NCT05997342 2025-08-11

A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Completed
36 enrolled
Other neoplasm

Advanced Malignant Neoplasm

NCT06344351 2025-05-22

A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Completed
27 enrolled
Other neoplasm

Advanced Malignant Neoplasm

NCT00244972 2017-04-27

Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer

National Cancer Institute (NCI)

Phase 1 Completed
74 enrolled
Other neoplasm

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡